Organigram (NASDAQ: OGI) reported fiscal first-quarter results after the bell on Tuesday that exceeded Wall Street's expectations. In addition to better-than-expected sales, the Canadian cannabis producer reported positive cash flows on an adjusted basis.
Organigram has just one cultivation and processing facility in New Brunswick, but it's generating revenue that grew 102% year over year to CA$25.2 million. That was CA$10.2 million more revenue than the average analyst had expected.
Image source: Getty Images.
In addition to exceeding top-line expectations, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) bounced back. Organigram reported adjusted EBITDA that reached CA$4.9 million after it dipped into negative territory during the previous three-month period.
During the fiscal fourth quarter, Organigram reported a CA$3.7 million provision for product returns and other adjustments. Investors were happy to see a much more reasonable $1.1 million provision during the latest period.
Organigram expects more positive cash flows in 2020, thanks in large part to a very efficient production facility. The cash cost to produce a gram of dried flower dropped from $0.66 per gram during the previous three-month period to just $0.61 per gram during the company's fiscal first quarter.
In December, Organigram began shipping its first vaporizer cartridges, and distillate pens will probably go out before the end of the month. The company also expects to start selling a line of cannabis-infused chocolates by the end of the first quarter.
10 stocks we like better than OrganiGram Holdings
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and OrganiGram Holdings wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of December 1, 2019
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.